PFM
AZN icon

PacWest Financial Management’s AstraZeneca AZN Stock Holding History

PacWest Financial Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,190
Closed -$218K – 82
2015
Q2 		$218K Hold
3,190
– – 0.15% 83
2015
Q1 		$218K Sell
3,190
-100
-3% -$6.95K 0.15% 82
2014
Q4 		$232K Sell
3,290
-110
-3% -$7.88K 0.16% 84
2014
Q3 		$243K Hold
3,400
– – 0.18% 81
2014
Q2 		$253K Hold
3,400
– – 0.19% 80
2014
Q1 		$221K Hold
3,400
– – 0.17% 88
2013
Q4 		$202M Buy
+3,400
New +$185K 60.81% 1

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PacWest Financial Management's AZN Position: Q3 2015 in Review

PacWest Financial Management sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 3,190 shares — an estimated $218K sold.

PacWest Financial Management first reported a position in AZN in Q4 2013 and held it in 7 quarters. The position peaked at $202M in Q4 2013. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

  • PacWest Financial Management reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
  • PacWest Financial Management sold 3,190 AstraZeneca shares in Q3 2015, an estimated $218K.
  • PacWest Financial Management first reported a position in AstraZeneca in Q4 2013 and held it in 7 quarters.
  • PacWest Financial Management's AstraZeneca position peaked at $202M in Q4 2013.
  • 371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on PacWest Financial Management's 13F filing for Q3 2015, filed 9 Oct 2015.